[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546790":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":49,"collaborators":18,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":18,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":18,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"West China Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ANH group","EXPERIMENTAL","Participants will undergo individualized ANH based on the West China Liu's Score after anesthetic induction. The decision of autologous blood transfusion or allogeneic red cell transfusion will be made according to the West China Liu's Score.",[13],"Procedure: Individualized ANH",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","Participants will be treated as the routine clinical practice. The decision of blood transfusion will be guided as the transfusion guideline.",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"PROCEDURE","Individualized ANH",[9],[25],{"name":26,"affiliation":5,"role":27},"Ren Liao","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Ren Liao, M.D.","CONTACT","+86-18980602177","liaoren7733@163.com",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":18},"West China Hospital of Sichuan University","RECRUITING","Chengdu","Sichuan","610041","China","CN",{"type":44,"coordinates":45},"Point",[46,47],104.06667,30.66667,{"lat":47,"lon":46},{"type":27,"investigatorFullName":26,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Professor","100546790","individualized-anh-for-non-cardiac-surgery-100546790",false,"NCT06399536","Individualized ANH for Non-cardiac Surgery","Individualized Acute Normovolemic Hemodilution for Non-cardiac Surgery With Anticipated High-dose Red Cells Transfusion","Inclusion Criteria:\n\n* Patients undergoing elective non-cardiac surgery with an anticipated red blood cells transfusion \\>8 units (or 1600ml)\n* Aged 18\\~75 years\n* Preoperative Hb level \\> 120g\u002FL for men and \\> 110g\u002FL for women.\n\nExclusion Criteria:\n\n* Refusal of blood transfusion\n* Cardiopulmonary insufficiency\n* Cerebrovascular disease\n* Renal impairment\n* Hemoglobinopathies or blood system diseases\n* Other situations not suitable for inclusion in clinical trial.","ALL","18 Years","75 Years",{"count":62,"type":63},40,"ESTIMATED","INTERVENTIONAL",[66],"NA","In this trial, we proposed an individualized acute normovolemic hemodilution (ANH), and conduct a randomized controlled trial to testify the effect of individualized ANH on red cells requirement for non-cardiac surgeries with anticipating major blood loss in adults.",[69,70],"Transfusion Related Complication","Hemodilution",[72,73,74],"acute normovolemic hemodilution","individualized blood transfusion","clinical trial","2024-12-01",{"date":77,"type":78},"2024-12-04","ACTUAL",{"date":80,"type":78},"2024-06-01",{"date":82,"type":63},"2026-12-31",{"name":5,"class":6},1]